Global $42.1 Bn Women's Health Market to 2023

Dublin, Nov. 08, 2017 -- The "Global Women's Health Market 2017-2023" report has been added to Research and Markets' offering.

The world population is constantly increasing & was estimated to be approximately 7.5 billion in April 2017. Women accounted for 49.6% of the total world population. They form an important part of the society and hence, the concerns regarding women's health are pivotal for the overall well-being of the society. Women have higher life expectancy than men but a longer life does not ensure a healthy life.

Women health has long been a neglected issue, worldwide. Women undergo several biological, physical & psychological changes during their lifetime. These reoccurring changes, along with ageing, consequently lead to several health issues and related problems. The world population is ageing faster and women accounted for 54% of the population belonging to the age group of 60 years or over, in 2015. This percentage is expected to increase in the coming years. The different health issues that women face include infertility, hormonal changes, postmenopausal disorders and urinary infections, among others. The use of contraceptives by women is another issue that needs to be addressed. The market analysis includes an in-depth examination of the key ecosystem players and the key strategies & developments taking place in this market. Additionally, it includes the market dynamics (market drivers, opportunities and challenges) and industry analysis.

The answers to the following key questions can be derived from this report:

• What are the major market drivers, challenges and opportunities in the global women's health market?
• How did the women's health market evolve in the past and what is its scope in the future?
• What is the market share of the leading segments and sub-segments of the global women's health market in 2016 and 2023?
• How will each segment of the global women's health market grow during the forecast period and what will be the revenue generated by each of the segments by the end of 2023?
• What are the influencing factors that may affect the market share of the key players?
• How will the industry evolve during the forecast period 2016- 2023?
• What are the key developmental strategies that are being implemented by the key players to stand out in this market?
• How the market has been segmented on the basis of application?
• What are the treatment options for postmenopausal symptoms?
• What is the estimated value for menopausal hot flash market?
• What is the value of different types of contraceptives in the market?
• What will be the value of hormonal contraceptives segment by 2023?
• Which geographical location will contribute to the highest sales of the products?
  

Key Topics Covered:

Executive Summary

1 Report Scope
1.1 Scope of the Report
1.2 Global Women's Health Market Segmentation
1.3 Key Learnings
1.4 Research Methodology

2 Market Overview
2.1 Introduction

3 Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities

4 Competitive Insights
4.1. Share of Key Developments & Strategies
4.1.1. Collaborations/ Partnerships/ Joint Ventures/ Licensing Agreements
4.1.2. Regulatory Approvals
4.1.3. Mergers and Acquisitions
4.1.4. Business Expansions and Product Acquisitions
4.1.5. Product Launches
4.1.6. Others

5 Industry Insights
5.1. Regulatory Scenario
5.2. Patent Landscape

6 Global Women's Health Market, by Application
6.1. Segmentation of Global Women's Health Market, by Application
6.2. Reproductive Health
6.2.1. Infertility
6.2.2. Endometriosis
6.2.3. Poly Cystic Ovarian Syndrome (PCOS)
6.2.4. Contraceptives
6.2.4.1. Method of Contraceptive And Effectiveness
6.2.4.2. Types of Contraceptives
6.3. Post Menopausal Health
6.3.1. Menopause
6.3.2. Post Menopausal Osteoporosis
6.4. Urological Disorders
6.4.1. Urinary Incontinence
6.4.2. Urinary Tract Infection
6.4.3. Others

7 Global Women's Health Market, by Product Type
7.1. Introduction
7.2. Devices
7.2.1. Intra Uterine Devices
7.2.2. Vaginal Rings
7.2.3 Implants
7.2.4. Female Condoms
7.3. Drugs
7.3.1. Drugs for Treatment of Menopause
7.3.2. Drugs for Treatment of Menopausal Hot Flashes
7.4. Pharmaceutical Pipeline

8 Global Women's Health Market, by Geography

9 Company Profiles

• Abbott Laboratories
• AGILE THERAPEUTICS
• Allergan plc.
• Amgen Inc.
• AstraZeneca PLC
• Bayer AG
• Eli Lilly and Company
• Enteris BIOPHARMA, Inc
• Evestra, Inc
• FERRING PHARMACEUTICALS
• GEDEON RICHTER PLC
• GlaxoSmithKline Plc
• HRA Pharma
• JDS THERAPEUTICS,LLC
• NEUROCRINE BIOSCIENCES, INC.
• NOVEN PHARMACEUTICALS,Inc.
• Novartis International AG
• Novo Nordisk
• Pfizer Inc.
• Radius Health Inc.
• Teva Pharmaceuticals Industries Limited
• TherapeuticsMD, Inc.
• VALEANT PHARMACEUTICALS INTERNATIONAL Inc.
• VERTICAL PHARMACEUTICALS,LLC
• VERU HEALTHCARE

For more information about this report visit https://www.researchandmarkets.com/research/mq85jz/global_womens

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Women's Health